Back to search
FDAFDA · Food and drugs·Recall number Z-0578-2015

Oxoid Legionella BCYE Growth Supplement packaged in packs of 10-100ml vials. A growth supplement for the isolation of Legionella.

Published December 17, 2014 · Recall initiated: November 13, 2014

Summary

FDA records medical device Class II recall Z-0578-2015, published December 17, 2014 and initiated November 13, 2014. Recalling firm: Remel Inc; Status: Terminated; Reported quantity: 1/10/100 ml/vials/packs; Lot: Lot number: 1374439, Exp: 31 Aug 2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Use of the product could result in inadequate recovery of Legionella pneumophila which could result in false negative reporting.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Remel Inc
Distributor
Nationwide Distribution to FL
Lot
Lot number: 1374439, Exp: 31 Aug 2015
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Oxoid Legionella BCYE Growth Supplement packaged in packs of 10-100ml vials. A growth supplement for the isolation of Legionella. recalled?

Yes. FDA published recall Z-0578-2015 on December 17, 2014. Reported hazard: Use of the product could result in inadequate recovery of Legionella pneumophila which could result in false negative reporting.

What should I do if I have this product?

Voluntary: Firm initiated · Letter